These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7736535)

  • 21. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
    Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P
    J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.
    Cope AP; Gibbons DL; Aderka D; Foxwell BM; Wallach D; Maini RN; Feldmann M; Brennan FM
    Cytokine; 1993 May; 5(3):205-12. PubMed ID: 8218932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR; García M; Rey L; Cacabelos R
    J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions.
    Mantovani G; Macciò A; Massa E; Lai P; Manca G; Mudu C; Versace R; Pusceddu G
    Oncol Rep; 1999; 6(1):235-9. PubMed ID: 9864435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
    Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
    Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of lymphocyte proliferation in human immunodeficiency virus infection after recombinant interleukin-2 treatment.
    Afzelius P; Nielsen SD; Nielsen JO; Hansen JE
    Scand J Infect Dis; 1999; 31(5):437-42. PubMed ID: 10576122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients.
    Curti BD; Ochoa AC; Urba WJ; Alvord WG; Kopp WC; Powers G; Hawk C; Creekmore SP; Gause BL; Janik JE; Holmlund JT; Kremers P; Fenton RG; Miller L; Sznol M; Smith JW; Sharfman WH; Longo DL
    J Immunother Emphasis Tumor Immunol; 1996 Jul; 19(4):296-308. PubMed ID: 8877723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and role of p75 interleukin 2 receptor on human monocytes.
    Espinoza-Delgado I; Ortaldo JR; Winkler-Pickett R; Sugamura K; Varesio L; Longo DL
    J Exp Med; 1990 May; 171(5):1821-6. PubMed ID: 2110244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets.
    Nishikawa K; Saito S; Morii T; Kato Y; Narita N; Ichijo M; Ohashi Y; Takeshita T; Sugamura K
    Int Immunol; 1990; 2(6):481-6. PubMed ID: 1707657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis.
    Godot V; Harraga S; Deschaseaux M; Bresson-Hadni S; Gottstein B; Emilie D; Vuitton DA
    Eur Cytokine Netw; 1997 Dec; 8(4):401-8. PubMed ID: 9459621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
    Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo activated cord blood lymphocytes express high affinity interleukin-2 receptor: evaluation of their responsiveness to in vitro stimulation with recombinant interleukin-2.
    Montagna D; Moretta A; Marconi M; Mingrat G; Gasparoni A; Giarola M; Maccario R
    Biol Neonate; 1992; 62(6):385-94. PubMed ID: 1472581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressed PMNC blastogenic response in patients with cancer of the head and neck: a study of IL-2 production, IL-2 consumption, and IL-2 receptor expression.
    Eskinazi DP; Perna JJ; Ershow AG; Mihail RC
    Laryngoscope; 1989 Feb; 99(2):151-7. PubMed ID: 2783615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts.
    Pizzolo G; Rigo A; Zanotti R; Vinante F; Vincenzi C; Cassatella M; Carra G; Castaman G; Chilosi M; Semenzato G
    Leukemia; 1993 Mar; 7(3):418-25. PubMed ID: 8445947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the interleukin 2 receptor beta chain (p75) in renal transplantation--applicability of anti-interleukin-2 receptor beta chain monoclonal antibody.
    Niguma T; Sakagami K; Kawamura T; Haisa M; Fujiwara T; Kusaka S; Uda M; Orita K
    Transplantation; 1991 Aug; 52(2):296-302. PubMed ID: 1831304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
    Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
    Audrain M; Boeffard F; Soulillou JP; Jacques Y
    J Immunol; 1991 Feb; 146(3):884-92. PubMed ID: 1988501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis.
    Neidhart M; Pataki F; Schönbächler J; Brühlmann P
    Rheumatol Int; 1996; 16(2):77-87. PubMed ID: 8853229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.